Accéder au contenu
Merck

Marked potentiation of activity of beta-lactams against methicillin-resistant Staphylococcus aureus by corilagin.

Antimicrobial agents and chemotherapy (2001-10-16)
M Shimizu, S Shiota, T Mizushima, H Ito, T Hatano, T Yoshida, T Tsuchiya
RÉSUMÉ

We found that an extract of Arctostaphylos uva-ursi markedly reduced the MICs of beta-lactam antibiotics, such as oxacillin and cefmetazole, against methicillin-resistant Staphylococcus aureus. We isolated the effective compound and identified it as corilagin. Corilagin reduced the MICs of various beta-lactams by 100- to 2,000-fold but not the MICs of other antimicrobial agents tested. The effect of corilagin and oxacillin was synergistic. Corilagin showed a bactericidal action when added to the growth medium in combination with oxacillin.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Corilagin